{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:38:32Z","timestamp":1794641912096,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32422-y","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:35:28Z","timestamp":1765838128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Protein domain-specific genotype\u2013phenotype correlation study of neurofibromatosis type 1"],"prefix":"10.1038","volume":"16","author":[{"given":"Min","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Strphanie KL.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Ming","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley SW.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Man-Kit","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tak-Wah","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Fai-Man","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"32422_CR1","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ebiom.2018.09.039","volume":"36","author":"O Isakov","year":"2018","unstructured":"Isakov, O., Wallis, D., Evans, D. G. & Ben-Shachar, S. Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture. EBioMedicine 36, 508\u2013516. https:\/\/doi.org\/10.1016\/j.ebiom.2018.09.039 (2018).","journal-title":"EBioMedicine"},{"key":"32422_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/labinvest.2016.142","volume":"97","author":"M Kiuru","year":"2017","unstructured":"Kiuru, M. & Busam, K. J. The NF1 gene in tumor syndromes and melanoma. Lab. Invest. 97, 146\u2013157. https:\/\/doi.org\/10.1038\/labinvest.2016.142 (2017).","journal-title":"Lab. Invest."},{"key":"32422_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrc3911","volume":"15","author":"N Ratner","year":"2015","unstructured":"Ratner, N. & Miller, S. J. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat. Rev. Cancer 15, 290\u2013301. https:\/\/doi.org\/10.1038\/nrc3911 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"32422_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fgene.2018.00270","volume":"9","author":"M Xu","year":"2018","unstructured":"Xu, M. et al. Identification of mutation regions on NF1 responsible for high- and low-risk development of optic pathway glioma in neurofibromatosis type I. Front. Genetics 9, 270. https:\/\/doi.org\/10.3389\/fgene.2018.00270 (2018).","journal-title":"Front. Genetics"},{"key":"32422_CR5","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","volume":"23","author":"E Legius","year":"2021","unstructured":"Legius, E. et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet. Med. 23, 1506\u20131513. https:\/\/doi.org\/10.1038\/s41436-021-01170-5 (2021).","journal-title":"Genet. Med."},{"key":"32422_CR6","unstructured":"Friedman, J. M. Neurofibromatosis 1. GeneReviews (2022)."},{"key":"32422_CR7","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/ejhg.2014.243","volume":"23","author":"V Pinna","year":"2015","unstructured":"Pinna, V. et al. p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas. Europ. J. Human Genet. 23, 1068\u20131071. https:\/\/doi.org\/10.1038\/ejhg.2014.243 (2015).","journal-title":"Europ. J. Human Genet."},{"key":"32422_CR8","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/genes13071130","volume":"13","author":"F Napolitano","year":"2022","unstructured":"Napolitano, F. et al. Genotype-phenotype correlations in neurofibromatosis type 1: identification of novel and recurrent NF1 gene variants and correlations with neurocognitive phenotype. Genes 13, 1130 (2022).","journal-title":"Genes"},{"key":"32422_CR9","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1038\/s41467-018-03910-9","volume":"9","author":"C DeBoever","year":"2018","unstructured":"DeBoever, C. et al. Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study. Nat. Commun. 9, 1612. https:\/\/doi.org\/10.1038\/s41467-018-03910-9 (2018).","journal-title":"Nat. Commun."},{"key":"32422_CR10","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.jmb.2019.04.009","volume":"431","author":"S Ittisoponpisan","year":"2019","unstructured":"Ittisoponpisan, S. et al. Can predicted protein 3D structures provide reliable insights into whether missense variants are disease associated?. J. Mol. Biol. 431, 2197\u20132212. https:\/\/doi.org\/10.1016\/j.jmb.2019.04.009 (2019).","journal-title":"J. Mol. Biol."},{"key":"32422_CR11","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1021\/ct401022c","volume":"10","author":"M Li","year":"2014","unstructured":"Li, M., Petukh, M., Alexov, E. & Panchenko, A. R. Predicting the impact of missense mutations on protein-protein binding affinity. J Chem Theory Comput 10, 1770\u20131780. https:\/\/doi.org\/10.1021\/ct401022c (2014).","journal-title":"J Chem Theory Comput"},{"key":"32422_CR12","doi-asserted-by":"publisher","first-page":"1172947","DOI":"10.3389\/fgene.2023.1172947","volume":"14","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. Functional identification of two novel variants and a hypomorphic variant in ASS1 from patients with Citrullinemia type I. Front. Genet. 14, 1172947. https:\/\/doi.org\/10.3389\/fgene.2023.1172947 (2023).","journal-title":"Front. Genet."},{"key":"32422_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30 (2015).","journal-title":"Genet. Med."},{"key":"32422_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1472-6807-14-10","volume":"14","author":"W Qiu","year":"2014","unstructured":"Qiu, W. et al. Structural insights into Noonan\/LEOPARD syndrome-related mutants of protein-tyrosine phosphatase SHP2 (PTPN11). BMC Struct. Biol. 14, 10. https:\/\/doi.org\/10.1186\/1472-6807-14-10 (2014).","journal-title":"BMC Struct. Biol."},{"key":"32422_CR15","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/hmg\/ddy412","volume":"28","author":"M Motta","year":"2018","unstructured":"Motta, M. et al. Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling. Hum. Mol. Genet. 28, 1007\u20131022. https:\/\/doi.org\/10.1093\/hmg\/ddy412 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"32422_CR16","doi-asserted-by":"publisher","first-page":"104474","DOI":"10.1016\/j.ejmg.2022.104474","volume":"65","author":"SKL Ho","year":"2022","unstructured":"Ho, S. K. L. et al. Old and new perspectives on Neurofibromatosis type 1: Clinical and molecular characterization of 832 patients from a single centre over 16 years. Eur. J. Med. Genetics 65, 104474. https:\/\/doi.org\/10.1016\/j.ejmg.2022.104474 (2022).","journal-title":"Eur. J. Med. Genetics"},{"key":"32422_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10048-009-0178-0","volume":"10","author":"M Upadhyaya","year":"2009","unstructured":"Upadhyaya, M. et al. The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas. Neurogenetics 10, 251\u2013263. https:\/\/doi.org\/10.1007\/s10048-009-0178-0 (2009).","journal-title":"Neurogenetics"},{"key":"32422_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/(SICI)1098-1004(1999)13:3","volume":"13","author":"H Peters","year":"1999","unstructured":"Peters, H., L\u00fcder, A., Harder, A., Schuelke, M. & Tinschert, S. Mutation screening of neurofibromatosis type 1 (NF1) exons 28 and 29 with single strand conformation polymorphism (SSCP): Five novel mutations, one recurrent transition and two polymorphisms in a panel of 118 unrelated NF1 patients. Hum. Mutat. 13, 258\u2013258. https:\/\/doi.org\/10.1002\/(SICI)1098-1004(1999)13:3 (1999).","journal-title":"Hum. Mutat."},{"key":"32422_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1086\/498454","volume":"77","author":"A De Luca","year":"2005","unstructured":"De Luca, A. et al. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-noonan syndrome. Am. J. Hum. Genet. 77, 1092\u20131101. https:\/\/doi.org\/10.1086\/498454 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"32422_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1385\/jmn:31:03:273","volume":"31","author":"S Bendova","year":"2007","unstructured":"Bendova, S. et al. Novel mutations in the NF1 gene in Czech patients with neurofibromatosis type 1. J. Mol. Neurosci. 31, 273\u2013279. https:\/\/doi.org\/10.1385\/jmn:31:03:273 (2007).","journal-title":"J. Mol. Neurosci."},{"key":"32422_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/humu.23929","volume":"41","author":"M Koczkowska","year":"2020","unstructured":"Koczkowska, M. et al. Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1. Hum. Mutat. 41, 299\u2013315. https:\/\/doi.org\/10.1002\/humu.23929 (2020).","journal-title":"Hum. Mutat."},{"key":"32422_CR22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41436-018-0269-0","volume":"21","author":"M Koczkowska","year":"2019","unstructured":"Koczkowska, M. et al. Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation. Genet. Med. 21, 867\u2013876. https:\/\/doi.org\/10.1038\/s41436-018-0269-0 (2019).","journal-title":"Genet. Med."},{"key":"32422_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ajhg.2017.12.001","volume":"102","author":"M Koczkowska","year":"2018","unstructured":"Koczkowska, M. et al. Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844\u2013848. Am. J. Hum. Genet. 102, 69\u201387. https:\/\/doi.org\/10.1016\/j.ajhg.2017.12.001 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"32422_CR24","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/humu.22832","volume":"36","author":"K Rojnueangnit","year":"2015","unstructured":"Rojnueangnit, K. et al. High incidence of noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype-phenotype correlation. Hum. Mutat. 36, 1052\u20131063. https:\/\/doi.org\/10.1002\/humu.22832 (2015).","journal-title":"Hum. Mutat."},{"key":"32422_CR25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/ajmg.a.36313","volume":"164","author":"S Ekvall","year":"2014","unstructured":"Ekvall, S. et al. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-noonan syndrome. Am. J. Med. Genet. Part A 164, 579\u2013587. https:\/\/doi.org\/10.1002\/ajmg.a.36313 (2014).","journal-title":"Am. J. Med. Genet. Part A"},{"key":"32422_CR26","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/ejhg.2015.93","volume":"23","author":"C Santoro","year":"2015","unstructured":"Santoro, C. et al. Arg (1809) substitution in neurofibromin: further evidence of a genotype-phenotype correlation in neurofibromatosis type 1. Eur. J. Hum. Genet. 23, 1460\u20131461. https:\/\/doi.org\/10.1038\/ejhg.2015.93 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"32422_CR27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1651-2227.2008.01170.x","volume":"98","author":"A-M Nystr\u00f6m","year":"2009","unstructured":"Nystr\u00f6m, A.-M. et al. A severe form of Noonan syndrome and autosomal dominant caf\u00e9-au-lait spots \u2013 evidence for different genetic origins. Acta Paediatr. 98, 693\u2013698. https:\/\/doi.org\/10.1111\/j.1651-2227.2008.01170.x (2009).","journal-title":"Acta Paediatr."},{"key":"32422_CR28","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1210\/jc.2006-2833","volume":"92","author":"B Bausch","year":"2007","unstructured":"Bausch, B. et al. Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J. Clin. Endocrinol. Metab. 92, 2784\u20132792. https:\/\/doi.org\/10.1210\/jc.2006-2833 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"32422_CR29","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/ajmg.a.33386","volume":"152","author":"I Bottillo","year":"2010","unstructured":"Bottillo, I. et al. Germline mosaicism in neurofibromatosis type 1 due to a paternally derived multi-exon deletion. Am. J. Med. Genet. A. 152, 1467\u20131473. https:\/\/doi.org\/10.1002\/ajmg.a.33386 (2010).","journal-title":"Am. J. Med. Genet. A."},{"key":"32422_CR30","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1002\/humu.24487","volume":"43","author":"HCW Douben","year":"2022","unstructured":"Douben, H. C. W. et al. High-yield identification of pathogenic NF1 variants by skin fibroblast transcriptome screening after apparently normal diagnostic DNA testing. Hum Mutat 43, 2130\u20132140. https:\/\/doi.org\/10.1002\/humu.24487 (2022).","journal-title":"Hum Mutat"},{"key":"32422_CR31","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ajhg.2015.06.002","volume":"97","author":"MC Hsiao","year":"2015","unstructured":"Hsiao, M. C. et al. Decoding NF1 intragenic copy-number variations. Am J Hum Genet 97, 238\u2013249. https:\/\/doi.org\/10.1016\/j.ajhg.2015.06.002 (2015).","journal-title":"Am J Hum Genet"},{"key":"32422_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s10038-019-0695-0","volume":"65","author":"E Kang","year":"2020","unstructured":"Kang, E. et al. Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types. J. Hum. Genet. 65, 79\u201389. https:\/\/doi.org\/10.1038\/s10038-019-0695-0 (2020).","journal-title":"J. Hum. Genet."},{"key":"32422_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/jmg.2005.033795","volume":"43","author":"KK Mantripragada","year":"2006","unstructured":"Mantripragada, K. K. et al. Identification of novel deletion breakpoints bordered by segmental duplications in the NF1 locus using high resolution array-CGH. J. Med. Genet. 43, 28\u201338. https:\/\/doi.org\/10.1136\/jmg.2005.033795 (2006).","journal-title":"J. Med. Genet."},{"key":"32422_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-022-02476-3","volume":"142","author":"L Pacot","year":"2023","unstructured":"Pacot, L. et al. Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1. Hum. Genet. 142, 1\u20139. https:\/\/doi.org\/10.1007\/s00439-022-02476-3 (2023).","journal-title":"Hum. Genet."},{"key":"32422_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1897-4287-9-6","volume":"9","author":"G Ponti","year":"2011","unstructured":"Ponti, G. et al. Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. Hered Cancer Clin. Pract. 9, 6. https:\/\/doi.org\/10.1186\/1897-4287-9-6 (2011).","journal-title":"Hered Cancer Clin. Pract."},{"key":"32422_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jns.2018.10.006","volume":"395","author":"M Tsipi","year":"2018","unstructured":"Tsipi, M. et al. Phenotypic expression of a spectrum of Neurofibromatosis Type 1 (NF1) mutations identified through NGS and MLPA. J. Neurol. Sci. 395, 95\u2013105. https:\/\/doi.org\/10.1016\/j.jns.2018.10.006 (2018).","journal-title":"J. Neurol. Sci."},{"key":"32422_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/gcc.22503","volume":"57","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer. Genes Chromosomes Cancer 57, 19\u201327. https:\/\/doi.org\/10.1002\/gcc.22503 (2018).","journal-title":"Genes Chromosomes Cancer"},{"key":"32422_CR38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12929-018-0474-9","volume":"25","author":"Y-H Wu-Chou","year":"2018","unstructured":"Wu-Chou, Y.-H. et al. Genetic diagnosis of neurofibromatosis type 1: Targeted next- generation sequencing with multiple ligation-dependent probe amplification analysis. J. Biomed. Sci. 25, 72. https:\/\/doi.org\/10.1186\/s12929-018-0474-9 (2018).","journal-title":"J. Biomed. Sci."},{"key":"32422_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4103\/ijdvl.IJDVL_1037_18","volume":"86","author":"Y Zheng","year":"2020","unstructured":"Zheng, Y. et al. Two novel mutations of NF1 gene identified in Chinese patients with severe neurofibromatosis type 1. Indian J. Dermatol. Venereol. Leprol. 86, 76\u201381. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_1037_18 (2020).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"32422_CR40","doi-asserted-by":"publisher","first-page":"e3043","DOI":"10.1097\/md.0000000000003043","volume":"95","author":"L Zhu","year":"2016","unstructured":"Zhu, L. et al. Clinical and molecular characterization of NF1 patients: single-center experience of 32 patients from china. Medicine (Baltimore) 95, e3043. https:\/\/doi.org\/10.1097\/md.0000000000003043 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"32422_CR41","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285\u2013291. https:\/\/doi.org\/10.1038\/nature19057 (2016).","journal-title":"Nature"},{"key":"32422_CR42","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 122. https:\/\/doi.org\/10.1186\/s13059-016-0974-4 (2016).","journal-title":"Genome Biol."},{"key":"32422_CR43","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/humu.20493","volume":"28","author":"K Wimmer","year":"2007","unstructured":"Wimmer, K. et al. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5\u2019 splice-site disruption. Hum Mutat 28, 599\u2013612. https:\/\/doi.org\/10.1002\/humu.20493 (2007).","journal-title":"Hum Mutat"},{"key":"32422_CR44","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/sj.embor.7400602","volume":"7","author":"I D\u2019Angelo","year":"2006","unstructured":"D\u2019Angelo, I., Welti, S., Bonneau, F. & Scheffzek, K. A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein. EMBO Rep 7, 174\u2013179. https:\/\/doi.org\/10.1038\/sj.embor.7400602 (2006).","journal-title":"EMBO Rep"},{"key":"32422_CR45","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jmb.2006.11.055","volume":"366","author":"S Welti","year":"2007","unstructured":"Welti, S., Fraterman, S., D\u2019Angelo, I., Wilm, M. & Scheffzek, K. The Sec14 homology module of neurofibromin binds cellular glycerophospholipids: mass spectrometry and structure of a lipid complex. J. Mol. Biol. 366, 551\u2013562. https:\/\/doi.org\/10.1016\/j.jmb.2006.11.055 (2007).","journal-title":"J. Mol. Biol."},{"key":"32422_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/humu.21405","volume":"32","author":"S Welti","year":"2011","unstructured":"Welti, S. et al. Structural and biochemical consequences of NF1 associated nontruncating mutations in the Sec14-PH module of neurofibromin. Hum. Mutat. 32, 191\u2013197. https:\/\/doi.org\/10.1002\/humu.21405 (2011).","journal-title":"Hum. Mutat."},{"key":"32422_CR47","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: A flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842. https:\/\/doi.org\/10.1093\/bioinformatics\/btq033 (2010).","journal-title":"Bioinformatics"},{"key":"32422_CR48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2307\/2982890","volume":"155","author":"GJG Upton","year":"2018","unstructured":"Upton, G. J. G. Fisher\u2019s exact test. J. R. Stat. Soc. Ser. A Stat. Soc. 155, 395\u2013402. https:\/\/doi.org\/10.2307\/2982890 (2018).","journal-title":"J. R. Stat. Soc. Ser. A Stat. Soc."},{"key":"32422_CR49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.21873\/invivo.11015","volume":"30","author":"C Yapijakis","year":"2016","unstructured":"Yapijakis, C., Pachis, N., Natsis, S. & Voumvourakis, C. Is Neurofibromatosis type 1\u2013noonan syndrome a phenotypic result of combined genetic and epigenetic factors?. In Vivo 30, 315\u2013320 (2016).","journal-title":"In Vivo"},{"key":"32422_CR50","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fgene.2018.00270","volume":"9","author":"M Xu","year":"2018","unstructured":"Xu, M. et al. Identification of mutation regions on NF1 responsible for high- and low-risk development of optic pathway glioma in neurofibromatosis type I. Front. Genet. 9, 270. https:\/\/doi.org\/10.3389\/fgene.2018.00270 (2018).","journal-title":"Front. Genet."},{"key":"32422_CR51","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3390\/cancers11121838","volume":"11","author":"G Melloni","year":"2019","unstructured":"Melloni, G. et al. Risk of optic pathway glioma in neurofibromatosis type 1: No evidence of genotype-phenotype correlations in a large independent cohort. Cancers 11, 1838 (2019).","journal-title":"Cancers"},{"key":"32422_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1687","volume":"361","author":"C Turnbull","year":"2018","unstructured":"Turnbull, C. et al. The 100 000 genomes project: Bringing whole genome sequencing to the NHS. BMJ 361, k1687. https:\/\/doi.org\/10.1136\/bmj.k1687 (2018).","journal-title":"BMJ"},{"key":"32422_CR53","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cell.2019.09.019","volume":"179","author":"D Wu","year":"2019","unstructured":"Wu, D. et al. Large-scale whole-genome sequencing of three diverse Asian populations in Singapore. Cell 179, 736\u2013749. https:\/\/doi.org\/10.1016\/j.cell.2019.09.019 (2019).","journal-title":"Cell"},{"key":"32422_CR54","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMsr1809937","volume":"381","author":"JC Denny","year":"2019","unstructured":"Denny, J. C. et al. The \u201cAll of Us\u201d Research Program. N Engl J Med 381, 668\u2013676. https:\/\/doi.org\/10.1056\/NEJMsr1809937 (2019).","journal-title":"N Engl J Med"},{"key":"32422_CR55","doi-asserted-by":"publisher","first-page":"290","DOI":"10.20517\/jtgg.2022.02","volume":"6","author":"A Chu","year":"2022","unstructured":"Chu, A. et al. Potentials and challenges of launching the pilot phase of Hong Kong Genome Project. J. Transl. Genet. Genomics 6, 290\u2013303. https:\/\/doi.org\/10.20517\/jtgg.2022.02 (2022).","journal-title":"J. Transl. Genet. Genomics"},{"key":"32422_CR56","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1038\/s41467-020-17526-5","volume":"11","author":"K Litchfield","year":"2020","unstructured":"Litchfield, K. et al. Escape from nonsense-mediated decay associates with anti-tumor immunogenicity. Nat. Commun. 11, 3800. https:\/\/doi.org\/10.1038\/s41467-020-17526-5 (2020).","journal-title":"Nat. Commun."},{"key":"32422_CR57","doi-asserted-by":"publisher","unstructured":"Ou, M. et al. Protein Domain-Specific Genotype-Phenotype Correlation Study of Neurofibromatosis Type 1. SSRN (2024). https:\/\/doi.org\/10.2139\/ssrn.4752924","DOI":"10.2139\/ssrn.4752924"}],"updated-by":[{"DOI":"10.1038\/s41598-026-41593-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32422-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32422-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32422-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:45:16Z","timestamp":1772088316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32422-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32422"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32422-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-41593-1","URL":"https:\/\/doi.org\/10.1038\/s41598-026-41593-1","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2709"}}